US 9550974
Derivation of embryonic stem cells
granted A61KA61K35/545A61P
Quick answer
US patent 9550974 (Derivation of embryonic stem cells) held by Astellas Institute for Regenerative Medicine expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Astellas Institute for Regenerative Medicine
- Grant date
- Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K35/545, A61P, A61P1/16, A61P13/12